publication date: May. 3, 2019

In Brief

USC and UCSF join Lazarex in IMPACT program to increase diversity in trials

USC Norris Comprehensive Cancer Center and UCSF Helen Diller Comprehensive Cancer Center joined a program with Lazarex Cancer Foundation program combining financial reimbursement, outreach, and educational programs to help cancer patients learn about and access advanced treatment in clinical trials.

The program, called IMPACT (IMproving Patient Access to Cancer Clinical Trials, is funded by Amgen Inc.

The ultimate goal of IMPACT is to create equal access to clinical trials for all patients and prove that by removing the financial barrier to participation that currently exists, enrollment, retention, and minority participation can be improved.

IMPACT seeks to educate patients about clinical trials as an opportunity for treatment of advanced cancers and to reimburse travel expenses for the patient and a companion that may be needed to get to a clinical trial site.

The Lazarex IMPACT Program will also be studied as a non-therapeutic interventional trial focused on educating cancer patients about clinical trials as a treatment option and presenting the possibility for financial reimbursement at the time of patient consent.

In addition, IMPACT coordinates a community outreach effort called NeighborGood with other community organizations, advisors, health clinics, and health fairs to raise awareness about topics like prevention, early diagnosis through screenings, clinical trial education, etc., aimed at improving patient health outcomes.

In a three-year pilot program at Massachusetts General Hospital, IMPACT improved patient enrollment by 29% and doubled minority participation.

 

Elaine Fuchs receives 2019 AACR-G.H.A. Clowes Memorial Award

Elaine Fuchs received the  59th AACR-G.H.A. Clowes Memorial Award to The award was presented … Continue reading USC and UCSF join Lazarex in IMPACT program to increase diversity in trials

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2019 The Cancer Letter Inc.